A recently published study by FMI expects the global central pain syndrome management industry size garnered a market value of US$ 60 Billion in 2023 to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the …